Heart failure & cardiomyopathiesCohort study

Prognostic Utility of Left Atrial Strain to Predict Thrombotic Events and Mortality in Amyloid Cardiomyopathy

JACC Cardiovasc ImagingPublished

  • Cohort study

Authors' conclusion

LA strain identifies ACM patients with high thrombotic risk (independent of AF) and improves current ACM-specific survival staging.

Study context

Population
Patients with AL or ATTR amyloid cardiomyopathy and no history of atrial fibrillation (AF) at diagnosis50.2% AL
Participants
448 patients
Exposure
Left atrial (LA) strain for prediction of thrombotic events and mortality
Outcome
Incident thrombotic event and mortality
Follow-up
Median 3.8 years

Main finding

As reported in the abstract

Thrombotic event (TE) and mortality, per SD decrease in LA strain
TE, per SD decrease
Hazard ratio (95% CI)P value
LA strain reservoir
2.22(1.27–3.85)
P = 0.006
LA contractile strain
2.63(1.25–5.00)
P = 0.01

Per SD decrease, as printed

HR

Mortality, per SD decrease in LA strain reservoir
1.32 (95% CI: 1.09-1.59; P < 0.001)
Mortality, per SD decrease in LA contractile strain
1.49 (95% CI: 1.22-1.75; P < 0.001)

Observational data: associations, not effects.

Further findings

C-statistic of survival staging systems with LA strain added

Mayo AL staging: 0.65 to 0.68 (reservoir) and 0.70 (contractile)
P ≤ 0.02
Mayo ATTR staging: 0.73 to 0.79 (reservoir) and 0.80 (contractile)
P < 0.001
Gillmore ATTR staging: 0.70 to 0.79 (reservoir) and 0.80 (contractile)
P < 0.001

Original publication

Prognostic Utility of Left Atrial Strain to Predict Thrombotic Events and Mortality in Amyloid Cardiomyopathy. JACC Cardiovasc Imaging. Published 12 April 2023. doi:10.1016/j.jcmg.2023.01.015

Summarised from the published abstract; every number is checked against it